Prothena reported 109.23M in EBIT for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -15301000 28.41M
Adamas Pharmaceuticals ADMS:US -5636000 3.52M
Agios Pharmaceuticals AGIO:US $ -91152000 70K
Akebia Therapeutics AKBA:US $ -54886000 24.46M
Alexion Pharmaceuticals ALXN:US $ 816.7M 185.9M
ALKERMES ALKS:US -19659000 24.08M
Alnylam Pharmaceuticals ALNY:US $ -181677000 35.52M
Amgen AMGN:US $ 2378M 45M
Biogen BIIB:US $ 858.6M 171.5M
Biomarin Pharmaceutical BMRN:US $ -35997000 47.67M
Bluebird Bio BLUE:US $ -196779000 44.06M
Exelixis EXEL:US $ 51.62M 71.39M
Gw Pharmaceuticals GWPH:US -21027000 1.78M
Intercept Pharmaceuticals ICPT:US $ -6218000 6.73M
Intra Cellular Therapies ITCI:US $ -77323830 8.18M
IONIS PHARMACEUT IONS:US $ -85849000 12.88M
Macrogenics MGNX:US $ -52987000 12.71M
Nektar Therapeutics NKTR:US $ -113596000 3.39M
Neurocrine Biosciences NBIX:US $ 44.5M 23.3M
Prothena PRTA:US 109.23M 81.28M
Regeneron Pharmaceuticals REGN:US $ 1847.2M 1500M
Seattle Genetics SGEN:US $ -297963000 208.36M
Ultragenyx Pharmaceutical RARE:US $ -89828000 7.05M
Vertex Pharmaceuticals VRTX:US $ 1055.71M 1092.07M
Xoma XOMA:US $ -3345000 281K
YTE INCY:US $ 247.47M 92.16M